Access to TB drug bedaquiline, a backbone medicine for drug-resistant TB treatment regimens, remains out of reach for too many Geneva, 26 April 2023 – Ahead of Johnson & Johnson’s (J&J) annual shareholders meeting, the
Cyrus Paye, MSF Project Coordinator, describes the situation in North Darfur Since Saturday, April 15, intense fighting has been taking place between the Sudanese Armed Forces (SAF) and the Rapid Support Forces (RSF) in Khartoum
Dr Ghazali Babiker, country director for MSF in Sudan, shares his account of the current humanitarian emergency. Everywhere in the country, and especially in Khartoum, Darfur, North Kordofan and Gedaref states, our teams face serious
Since Saturday 15 April, intense fighting has been taking place between the Sudanese Armed Forces (SAF) and the Rapid Support Forces (RSF) in Khartoum and other parts of Sudan. Many people, including healthcare workers, are
In Türkiye the consequences of this February’s devastating earthquakes are all too visible in destroyed buildings, makeshift camps and rebuilding efforts widespread in affected areas. With the coming of spring, heavy rain has caused flooding,
On February 6, 2023, magnitude 7.8 and 7.6 earthquakes struck southeast Türkiye and northwest of Syria, between 4:17 and 4:30 a.m. local time. The initial earthquake, which was centred near Gaziantep in south central Türkiye
No humanitarian organization can deliver assistance at full capacity without female staff Yesterday the IEA notified the UN that no Afghan woman is permitted to work for the UN in Afghanistan, and that this measure
With affordable generics likely years away, ViiV must make information public on supply of long-acting cabotegravir and global distribution plan to ensure access for people in high HIV burden low- and middle-income countries Geneva, 30
MSF teams in the world’s largest refugee camp in Bangladesh are overwhelmed by the ongoing outbreak of scabies and are calling on other health actors to take their responsibility. Ajmot Ullah is a 26-year-old Rohingya
Emergency alert In late 2022, MSF’s team in Southern Nations, Nationalities and People’s Region (SNNPR) of Ethiopia received an alert about an usually high number of deaths in the south Omo Valley among an isolated
Mumbai, 23 March 2023 – Today, the 2019 patent challenge by two tuberculosis (TB) survivors, Nandita Venkatesan and Phumeza Tisile, was successful: the Indian Patent Office rejected the US pharmaceutical corporation Johnson & Johnson’s (J&J)
Delhi, 22 March 2023 – Médecins Sans Frontières/Doctors Without Borders (MSF) called on governments and donors today to speed up access to new, shorter, safer and more effective treatments* for drug-resistant tuberculosis (DR-TB), as well
Sign up for our emails and get deeper insight into world and work of MSF!
